{"disease":{"id":"gene-mutation","name":"gene mutation"},"drugs":{"marketed":[{"drug_id":"talazoparib-with-enzalutamide","indication_name":"Metastatic castration-resistant prostate cancer (mCRPC) with BRCA1, BRCA2, or ATM gene mutations","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Talazoparib with enzalutamide","generic_name":"talazoparib-with-enzalutamide","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"PARP enzymes and androgen receptor","drug_class":"PARP inhibitor and androgen receptor inhibitor","quality_score":10,"revenue":"2194","mechanism":""},{"drug_id":"encorafenib","indication_name":"Unresectable malignant melanoma with BRAF gene mutation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Braftovi","generic_name":"encorafenib","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"RAF proto-oncogene serine/threonine-protein kinase","drug_class":"","quality_score":83,"revenue":"716","mechanism":"Braftovi works by blocking the activity of a specific protein called BRAF that is involved in cancer cell growth."},{"drug_id":"binimetinib","indication_name":"Unresectable malignant melanoma with BRAF gene mutation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mektovi","generic_name":"binimetinib","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Dual specificity mitogen-activated protein kinase kinase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Mektovi works by blocking a specific enzyme called MEK1, which is involved in sending signals that promote cancer cell growth."},{"drug_id":"mek162","indication_name":"Unresectable malignant melanoma with BRAF gene mutation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mektovi","generic_name":"mek162","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Dual specificity mitogen-activated protein kinase kinase 1","drug_class":"","quality_score":70,"revenue":null,"mechanism":"Mektovi works by blocking the MEK1 enzyme, which is a key player in the signaling pathway that promotes cancer cell growth."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT03358459","title":"Omics-based Precision Medicine of Epilepsy","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT00628745","title":"Transthyretin Amyloidosis Outcome Survey (THAOS)","phase":"","overall_status":"COMPLETED","enrollment_count":6718,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04322890","title":"Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Hunan Province Tumor Hospital","has_results":false},{"nct_id":"NCT02849977","title":"Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers","phase":"","overall_status":"COMPLETED","enrollment_count":5966,"lead_sponsor_name":"Rhythm Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02993068","title":"Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)","phase":"NA","overall_status":"SUSPENDED","enrollment_count":5200,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT01689584","title":"COsegregation of VARiants in Panel of Genes","phase":"NA","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT04294927","title":"TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University Medical Center Nijmegen","has_results":false},{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04585074","title":"Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Severance Hospital","has_results":false},{"nct_id":"NCT04541654","title":"Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05721326","title":"Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition","phase":"NA","overall_status":"COMPLETED","enrollment_count":1330,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":false},{"nct_id":"NCT06408402","title":"Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1300,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07450612","title":"Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"San Raffaele University","has_results":false},{"nct_id":"NCT06716580","title":"EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT03538639","title":"Vascular Disease Discovery Protocol","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT06584994","title":"Investigating the Role of Genetics in Disease Predisposition","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"The Wellcome Sanger Institute","has_results":false},{"nct_id":"NCT05420064","title":"An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04541381","title":"The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":860,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT07042984","title":"RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Fujian Medical University","has_results":false},{"nct_id":"NCT07413029","title":"French National Cohort of Patients With PRSS1 Mutations","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04574297","title":"An Observational Study on the Natural Course of Chronic Pancreatitis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":798,"lead_sponsor_name":"Changhai Hospital","has_results":true},{"nct_id":"NCT04759352","title":"Telephone Versus In-person Post-test Cancer Genetic Counseling","phase":"NA","overall_status":"UNKNOWN","enrollment_count":724,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT04369287","title":"Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia","phase":"","overall_status":"UNKNOWN","enrollment_count":654,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT05819905","title":"Radiomics for prEdiction of lunG cAncer biologY","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT05489549","title":"Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT05534854","title":"Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT04792463","title":"Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Mohamed Abdel-Rahman","has_results":false},{"nct_id":"NCT03175224","title":"APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":497,"lead_sponsor_name":"Apollomics Inc.","has_results":false},{"nct_id":"NCT03653546","title":"First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) Metastases","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":492,"lead_sponsor_name":"Alpha Biopharma (Jiangsu) Co., Ltd.","has_results":false},{"nct_id":"NCT04526106","title":"REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":490,"lead_sponsor_name":"Elevar Therapeutics","has_results":false},{"nct_id":"NCT06548919","title":"Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"SciClone Pharmaceuticals","has_results":false},{"nct_id":"NCT01945775","title":"A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":431,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04788927","title":"Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05310370","title":"HRD and Resistance to PAPPi in EOC Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT02760849","title":"Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":374,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04206072","title":"D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"Betta Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT06544577","title":"Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"SciClone Pharmaceuticals","has_results":false},{"nct_id":"NCT02194387","title":"Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":337,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05110950","title":"Endobronchial Ultrasound Needle Aspiration With and Without Suction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":306,"lead_sponsor_name":"Università Politecnica delle Marche","has_results":false},{"nct_id":"NCT02000622","title":"Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04830787","title":"Correlation Between Myocardial Deformation and Coronary Artery Tortuosity in Patients With Hypertrophic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Henan Provincial People's Hospital","has_results":false},{"nct_id":"NCT05898009","title":"Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT04388969","title":"World Data on Ambroxol for Patients With GD and GBA Related PD","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Shaare Zedek Medical Center","has_results":false},{"nct_id":"NCT05123326","title":"Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT03971318","title":"A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07199127","title":"Duodenal Polyposis Classification in FAP","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT05364294","title":"Molecular Diagnosis of Systemic Autoinflammatory Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT06708429","title":"Lynch Syndrome X-Talk of Enteral Mucosa With Immune System","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"San Raffaele University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}